PT Tempo Scan Pacific Tbk (IDX: TSPC)
Health Care · Pharmaceuticals · ID
Rp2,720.00
-2.86% today · +19.3% 1Y
PT Tempo Scan Pacific Tbk (IDX: TSPC) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $694.97M and employs 4,390 people.
Over the last twelve months the share price has gained 19.3%, trading between 2.19K and 3.22K.
Tweenvest scores PT Tempo Scan Pacific Tbk across four factors: quality 70/100, value 52/100, dividend 90/100. Its strongest factor is dividend.
TSPC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $694.97M
- Revenue (TTM)
- $811.46M
- P/E
- 8.29
- EPS
- 327.98
- Dividend yield
- 5.51%
- Beta (5Y)
- 0.14
- 52-week high
- Rp3,220.00
- 52-week low
- Rp2,190.00
- Avg volume (3M)
- —
- Shares outstanding
- 4.51B
- Employees
- 4,390
- Next earnings
- —
About PT Tempo Scan Pacific Tbk
PT Tempo Scan Pacific Tbk, an Indonesian company headquartered in Jakarta with an international presence, operates primarily across three core business segments: pharmaceuticals, consumer products and cosmetics, and distribution services. Its activities encompass the trading of pharmaceutical and medical devices, alongside the manufacturing of diverse goods such as soaps, herbal products, powdered milk, food and beverages, and plastic packaging. The company also produces and markets a variety of consumer goods, cosmetic lines, and household items. Products are sold under an extensive portfolio of brands, including Bodrex, Oskadon, Neo rheumacyl, Bodrexin, Contrexyn, Contrex, Oskadryl, Neodulax, Vidoran, Hemaviton, Neo Hormoviton, Polaris, Vitonal, Vitamin IPI, Neo rheumacyl Herbal, Wybert Herbal, Bodrexin Herbal, Herbalax, Marina, Natural Honey, Claudia, MY BABY, MY BABY Kids, Pure Baby, S.O.S, Total Care, and ULTIMA II. Beyond these, PT Tempo Scan Pacific Tbk offers a range of supplementary services, including property construction and leasing, warehousing and freight forwarding, advertising and promotion, research and development, and information technology and communication network systems. It also manages procurement, distribution, and marketing functions. Established in 1970, the company was formerly known as PT Scanchemie and functions as a subsidiary of PT Bogamulia Nagadi.
- ISIN
- ID1000104508
- Founded
- 1970
- Listed since
- Sep 29, 2005
- Exchange
- Indonesia Stock Exchange
- Currency
- IDR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,257.00 | +0.13% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.16 | +0.34% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.18 | -0.24% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.30 | -1.41% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.00 | -1.14% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.14 | +0.23% |
Figures last refreshed Aug 18, 2026.